Published in Bioessays on March 01, 2009
Regulation of erythropoietin production. J Physiol (2010) 1.74
Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol (2015) 0.97
Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO. Int J Nanomedicine (2012) 0.84
Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci (2003) 2.46
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38
Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23
Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell (2003) 2.11
Role of blood platelets in infection and inflammation. J Interferon Cytokine Res (2002) 2.01
Moderate altitude but not additional endurance training increases markers of oxidative stress in exhaled breath condensate. Eur J Appl Physiol (2009) 1.99
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J (2004) 1.90
Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res (2005) 1.65
Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett (2002) 1.60
Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem J (2005) 1.45
Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol (2011) 1.43
Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood (2005) 1.41
Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab (2008) 1.15
Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci (2009) 1.04
A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J (2005) 1.03
Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol (2002) 1.01
Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol (2004) 1.01
Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB. FASEB J (2002) 1.00
Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol (2002) 0.99
Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J (2007) 0.98
Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation. J Interferon Cytokine Res (2005) 0.98
Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol (2007) 0.97
Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J (2009) 0.95
Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology (2010) 0.94
Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol (2012) 0.94
Lack of functional erythropoietin receptors of cancer cell lines. Int J Cancer (2008) 0.94
Immunogenicity of rituximab in patients with severe pemphigus. Clin Immunol (2009) 0.94
Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother (2013) 0.91
Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann N Y Acad Sci (2005) 0.91
Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. Eur J Cancer (2006) 0.91
The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J Immunol Methods (2003) 0.89
Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab (2002) 0.89
Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood (2003) 0.88
Leptin and the skin: a new frontier. Exp Dermatol (2009) 0.87
VEGF production by primary human renal proximal tubular cells: requirement of HIF-1, PI3-kinase and MAPKK-1 signaling. Cell Physiol Biochem (2005) 0.86
Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J (2007) 0.86
Thrombopoietin: the novel hepatic hormone. News Physiol Sci (2002) 0.86
Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol (2009) 0.86
Thyrotropin powers human mitochondria. FASEB J (2010) 0.85
Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol (2008) 0.85
Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plasmodium falciparum malaria. Ann Hematol (2008) 0.83
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. MAbs (2015) 0.83
Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci (2005) 0.83
The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT/HIF-1β) is influenced by hypoxia and hypoxia-mimetics. Cell Physiol Biochem (2013) 0.82
Efficacy of recombinant erythropoietins: is there unity of international units? Nephrol Dial Transplant (2009) 0.82
Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model. Clin Cancer Res (2012) 0.81
Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy. Cell Physiol Biochem (2011) 0.81
Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing. J Mol Med (Berl) (2015) 0.81
Progress in detecting cell-surface protein receptors: the erythropoietin receptor example. Ann Hematol (2013) 0.81
A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. J Autoimmun (2002) 0.81
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol (2011) 0.80
Modulation of chemotherapy-induced human hair follicle damage by 17-beta estradiol and prednisolone: potential stimulators of normal hair regrowth by "dystrophic catagen" promotion? J Invest Dermatol (2008) 0.80
Austrian Moderate Altitude Study (AMAS 2000) - fluid shifts, erythropoiesis, and angiogenesis in patients with metabolic syndrome at moderate altitude (congruent with 1700 m). Eur J Appl Physiol (2002) 0.79
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial. Trials (2013) 0.79
Recombinant EPO production--points the nephrologist should know. Nephrol Dial Transplant (2007) 0.79
Problems in identifying functional erythropoietin receptors in cancer tissue. J Clin Oncol (2007) 0.79
Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys (2008) 0.78
Evaluation of the pharmacokinetics of two recombinant human erythropoietin preparations: epoetin zeta and epoetin alfa. 1st Communication: A monocentric, open, randomized, single dose, two-period crossover trial in healthy volunteers. Arzneimittelforschung (2008) 0.78
Evaluation of the pharmacokinetics of two recombinant human erythropoietin preparations: epoetin zeta and epoetin alfa. 2nd Communication: A monocentric, double-blind, randomized, single dose, three-period crossover trial in healthy volunteers. Arzneimittelforschung (2008) 0.78
'O', erythropoietin carbamoylation versus carbamylation. Nephrol Dial Transplant (2008) 0.77
Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy? Clin Lab (2010) 0.77
Autoreactive T cell responses in pemphigus and pemphigoid. Autoimmun Rev (2002) 0.77
Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a. Ther Drug Monit (2011) 0.76
Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia. Nephron Clin Pract (2006) 0.76
The elusive erythropoietin receptor. Nephrol Dial Transplant (2012) 0.75
Intolerability of cobalt salt as erythropoietic agent. Drug Test Anal (2013) 0.75
Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. J Am Acad Dermatol (2002) 0.75
Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination. Amyotroph Lateral Scler (2011) 0.75
Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome. Arch Gynecol Obstet (2006) 0.75
Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment. J Interferon Cytokine Res (2002) 0.75
Trehalose conserves expression of bullous pemphigoid antigen 180 during desiccation and freezing. J Immunol Methods (2003) 0.75
Does erythropoietin modulate human hair follicle melanocyte activities in situ? Exp Dermatol (2009) 0.75
Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1. FEBS Lett (2006) 0.75
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia. Onkologie (2005) 0.75
Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression. Cell Physiol Biochem (2015) 0.75
The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts. Exp Dermatol (2008) 0.75